Older lung cancer patients who have not responded to standard chemotherapy may be reluctant to continue treatment. Later-stage drug treatment, however, can be effective. Older patients often go under-treated because of concerns that they will not be able to tolerate certain toxic therapies.

A drug often used to treat kidney and liver cancer may also fight a type of lung cancer. New research, though, shows that it does not extend the lives of lung cancer patients.